NCT00230087View on ClinicalTrials.gov

Iron Depletion Therapy for Type 2 DM and NAFLD

PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

June 30, 2010

Study Completion Date

June 30, 2010

Conditions
Non-Alcoholic Fatty Liver DiseaseDiabetes Mellitus
Interventions
PROCEDURE

blood donation

phlebotomy until iron depleted

Trial Locations (1)

98195

University of Washington Medical Center, Seattle

All Listed Sponsors
lead

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

NCT00230087 - Iron Depletion Therapy for Type 2 DM and NAFLD | Biotech Hunter | Biotech Hunter